Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.290 | 1.610 | 0.320 |
Stocks | 98.710 | 98.710 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.929 | 19.348 |
Price to Book | 2.937 | 4.050 |
Price to Sales | 5.204 | 5.381 |
Price to Cash Flow | 14.868 | 15.826 |
Dividend Yield | 0.501 | 0.512 |
5 Years Earnings Growth | 51.090 | 25.708 |
Number of long holdings: 42
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.53 | 464.58 | -0.53% | |
Regeneron Pharma | US75886F1075 | 8.27 | 754.87 | +0.24% | |
Alnylam | US02043Q1076 | 7.26 | 253.74 | +0.15% | |
Moderna | US60770K1079 | 5.76 | 43.39 | +3.19% | |
Neurocrine | US64125C1099 | 4.72 | 126.67 | -0.97% | |
Amgen | US0311621009 | 4.68 | 280.07 | +0.02% | |
Denali Therapeutics | US24823R1059 | 4.14 | 25.16 | +1.94% | |
AbbVie | US00287Y1091 | 3.95 | 183.09 | +1.08% | |
BioNTech | US09075V1026 | 3.72 | 120.62 | +1.75% | |
argenx ADR | US04016X1019 | 3.59 | 614.51 | +1.21% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.7B | -0.05 | 0.50 | - | ||
LU1300848345 | 6.7B | 0.18 | 0.79 | - | ||
LU1520716801 | 4.28B | 5.67 | 3.97 | - | ||
LU1323611266 | 4.28B | 4.05 | 1.53 | - | ||
UBS Lux Equity Fund China Opportuni | 2.87B | 9.57 | -10.68 | 4.90 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review